Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omnicare | Contract Pharma
Breaking News, Promotions & Moves

Omnicare

John G. Figueroa has been appointed chief executive officer of Omnicare, Inc., effective January 1, 2011.

John G. Figueroa has been appointed chief executive officer of Omnicare, Inc., effective January 1, 2011. He also will serve as a member of the board of directors. He replaces James D. Shelton, who has served as Omnicare’s interim president and chief executive officer since August 2010. Mr. Shelton will serve as a new non-executive chairman of the board and will assist Mr. Figueroa during the transition period.

Mr. Figueroa joins the company from McKesson Corp., where he served as president of the U.S. Pharmaceutical Group, overseeing a $90 billion business with more than 7,000 employees. Prior to that, he held a number of positions at McKesson, including president of National Account Sales and Packaging and senior vice president of the Southwest Region. He also held several executive positions during his seven-year career at Baxter Healthcare Corp. and served as an officer in the U.S. Army.

“We are delighted to welcome John as Omnicare’s new chief executive pfficer,” said Mr. Shelton. “John has strong operational expertise, a broad knowledge of the industry and a deep understanding of the opportunities and challenges that Omnicare faces. He is a respected and proven leader and we are confident that he will help us reach our goals.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters